{"product_id":"kyowa-kirin-co-ltd-4151-financial-and-strategic-swot-analysis-review","title":"Kyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review","description":"\u003cp\u003eKyowa Kirin Co Ltd (4151) - Financial and Strategic SWOT Analysis Review- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.\u003c\/p\u003e\n\n\u003cp\u003eThe profile contains critical company information including:Business description – A detailed description of the company’s operations and business divisions.Corporate strategy – Analyst’s summarization of the company’s business strategy.SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.Company history – Progression of key events associated with the company.Major products and services – A list of major products, services and brands of the company.Key competitors – A list of key competitors to the company.Key employees – A list of the key executives of the company.Executive biographies – A brief summary of the executives’ employment history.Key operational heads – A list of personnel heading key departments\/functions.Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly\/semi-annual financial statements published by the company for 5 interims history.Highlights\u003c\/p\u003e\n\n\u003cp\u003eKyowa Kirin Co Ltd (Kyowa Kirin), a subsidiary of Kirin Holdings Co Ltd, is a biotechnology company focused on research and development. It is involved in the discovery, development, production and commercialization of pharmaceuticals and biotechnology products. The company offers drugs in the areas of nephrology, oncology, immunology and allergy, central nervous system among others. Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, angina pectoris, hypertension, allergic rhinitis, epilepsy, behavioral or personality disorders and others. The company operates through a network of subsidiaries in the US, Europe and Asia. Kyowa Kirin is headquartered in Tokyo, Japan.\u003c\/p\u003e\n\n\u003cp\u003eKyowa Kirin Co Ltd Key Recent Developments\u003c\/p\u003e\n\n\u003cp\u003eMar 28,2023: Kyowa Kirin completed construction of a new office building at Ube plant\u003cbr\u003e\nFeb 07,2023: Kyowa Kirin Announces Consolidated Financial Summary for Fiscal Year Ended December 31, 2022\u003cbr\u003e\nDec 22,2022: Kyowa Kirin to decide on construction of a new warehouse building at its Takasaki Plant\u003cbr\u003e\nDec 22,2022: Kyowa Kirin’s Ube plant to introduce large-scale solar power generation system\u003c\/p\u003e\n\n\u003cp\u003eKey benefits of buying this profile include:\u003c\/p\u003e\n\n\u003cp\u003eYou get detailed information about the company and its operations to identify potential customers and suppliers.\u003cbr\u003e\nThe profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.\u003c\/p\u003e\n\n\u003cp\u003eUnderstand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.\u003cbr\u003e\nThe company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.\u003c\/p\u003e\n\n\u003cp\u003eEquip yourself with information that enables you to sharpen your strategies and transform your operations profitably.\u003cbr\u003e\nOpportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and\/or technological threats are highlighted.\u003c\/p\u003e\n\n\u003cp\u003eScout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.\u003cbr\u003e\nFinancial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.\u003c\/p\u003e\n\n\u003cp\u003eGain key insights into the company for academic or business research.\u003cbr\u003e\nKey elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.\u003c\/p\u003e\n\n\u003cp\u003eNote: Some sections may be missing if data is unavailable for the company\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"April, 2023 \/ 67 Pages \/ MCW16229407","offer_id":47646948786482,"sku":null,"price":150.0,"currency_code":"USD","in_stock":true},{"title":"April, 2023 \/ 67 Pages \/ MCW16229408","offer_id":47646948819250,"sku":null,"price":150.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/kyowa-kirin-co-ltd-4151-financial-and-strategic-swot-analysis-review","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}